CXCL12 and neoplasm: mAbs, such as BMS-936564/MDX-1338 and LY2624587, could also suppress CXCR4/CXCL12 signaling pathways and inhibit tumor growth and metastasis in different animal models both in vitro and in vivo (42, 43).